Molecular profiling of chronic myeloid leukemia in eastern India
- 1 November 2006
- journal article
- Published by Wiley in American Journal of Hematology
- Vol. 81 (11) , 845-849
Abstract
Molecular breakpoint of the BCR‐ABL fusion gene has been characterized for 122 chronic myeloid leukemia patients. Out of 122 cases, 33 b2a2, 69 b3a2, 2 e1a2, and 2 e19a2 cases have been detected. Six coexpressed both b2a2 and b3a2 transcripts. All the coexpressing samples had an A>G polymorphism at the putative splice branchpoint in intron 13. The T>C polymorphism in exon 13, reported to be linked to coexpression, was not present in all the coexpressing patients. No correlation of transcript type with platelet count was detected. Those expressing b2a2 transcript were diagnosed at relatively younger age and with higher white blood cell count, in agreement with other reports. However, the correlation was not statistically significant. Am. J. Hematol., 2006.Keywords
This publication has 18 references indexed in Scilit:
- Molecular analysis in chronic granulocytic leukaemia: location of breakpoints within M-BCR and relationship with presentation platelet countsClinical and Laboratory Haematology, 2008
- Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemiaEuropean Journal Of Cancer Prevention, 2005
- CHRONIC MYELOGENOUS LEUKAEMIABritish Journal of Haematology, 2000
- Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probesLeukemia, 2000
- Monitoring chronic myeloid leukaemia therapy by real‐time quantitative PCR in blood is a reliable alternative to bone marrow cytogeneticsBritish Journal of Haematology, 1999
- A polymorphism in exon b2 of the major breakpoint cluster region (M‐bcr) identified in chronic myeloid leukaemia patientsBritish Journal of Haematology, 1998
- Analysis of molecular breakpoint and m‐RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survivalBritish Journal of Haematology, 1995
- Detection by polymerase chain reaction of BCR/ ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantationEuropean Journal of Cancer, 1995
- No correlation between site of breakpoint in the BCR gene and platelet counts in philadelphia chromosome-positive CMLLeukemia Research, 1992
- The relationship between the site of breakpoints within the bcr gene and thrombopoiesis of philadelphia-positive chronic myelocytic leukemiaLeukemia Research, 1991